Timely consistent transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company

摘要

ObjectivesEvidence requirements and assessment methods access differ between health technology assessment (HTA) agencies. The HTA Core Model^® provides a standardized approach to HTA, targeting evidence sharing and collaboration between participating HTA bodies. It is fit for purpose from an industry perspective and was used by pharmaceutical company Roche to develop a framework for internal assessment of evidence required for market access and coverage/reimbursement (“access evidence”).